MODERATE TO SEVERE GLABELLAR LINES
Clinical trials for MODERATE TO SEVERE GLABELLAR LINES explained in plain language.
Never miss a new study
Get alerted when new MODERATE TO SEVERE GLABELLAR LINES trials appear
Sign up with your email to follow new studies for MODERATE TO SEVERE GLABELLAR LINES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New injection aims to smooth away deep frown lines
Symptom relief Recruiting nowThis study tests a single injection of IPN10200 to see if it safely reduces moderate to severe frown lines between the eyebrows in adults. Some participants get the real treatment, others a placebo. The study also checks how well repeat doses work over time. About 1,300 adults wi…
Matched conditions: MODERATE TO SEVERE GLABELLAR LINES
Phase: PHASE3 • Sponsor: Ipsen • Aim: Symptom relief
Last updated May 17, 2026 14:00 UTC
-
New wrinkle treatment eveotox takes on botox in major trial
Symptom relief Recruiting nowThis study tests a new injection called Eveotox for moderate to severe frown lines between the eyebrows. About 669 adults aged 18 to 65 will receive either Eveotox, Botox, or a placebo to see how well it smooths wrinkles and if it is safe. The study also looks at effects of repea…
Matched conditions: MODERATE TO SEVERE GLABELLAR LINES
Phase: PHASE3 • Sponsor: JHM BioPharma (Tonghua) Co. , Ltd. • Aim: Symptom relief
Last updated May 17, 2026 13:58 UTC
-
New wrinkle treatment aims to erase frown lines in one shot
Symptom relief Recruiting nowThis study tests a single injection of IPN10200 to improve moderate to severe frown lines between the eyebrows in adults. About 300 participants will receive either the study drug or a placebo. The goal is to see if the treatment safely reduces wrinkle severity and boosts self-co…
Matched conditions: MODERATE TO SEVERE GLABELLAR LINES
Phase: PHASE3 • Sponsor: Ipsen • Aim: Symptom relief
Last updated May 04, 2026 16:31 UTC